Cargando…
Monitor for COVID-19 vaccine resistance evolution during clinical trials
Although less common than the evolution of antimicrobial drug resistance, vaccine resistance can and has evolved. How likely is it that COVID-19 vaccines currently in development will be undermined by viral evolution? We argue that this can be determined by repurposing samples that are already being...
Autores principales: | Kennedy, David A., Read, Andrew F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676675/ https://www.ncbi.nlm.nih.gov/pubmed/33166303 http://dx.doi.org/10.1371/journal.pbio.3001000 |
Ejemplares similares
-
Remote Monitoring in Clinical Trials During the COVID‐19 Pandemic
por: Izmailova, Elena S., et al.
Publicado: (2020) -
Potential drivers of virulence evolution in aquaculture
por: Kennedy, David A., et al.
Publicado: (2016) -
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
por: Desai, Aakash, et al.
Publicado: (2021) -
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
por: Brown, Ronald B.
Publicado: (2021) -
Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease
por: Cardozo, Timothy, et al.
Publicado: (2020)